175 related articles for article (PubMed ID: 22227616)
1. Development of a reporter bovine viral diarrhea virus and initial evaluation of its application for high throughput antiviral drug screening.
Fan ZC; Bird RC
J Virol Methods; 2012 Mar; 180(1-2):54-61. PubMed ID: 22227616
[TBL] [Abstract][Full Text] [Related]
2. Bovine viral diarrhea virus is a suitable viral vector for stable expression of heterologous gene when inserted in between N(pro) and C genes.
Fan ZC; Dennis JC; Bird RC
Virus Res; 2008 Dec; 138(1-2):97-104. PubMed ID: 18824056
[TBL] [Abstract][Full Text] [Related]
3. Suppression of bovine viral diarrhea virus replication by small interfering RNA and short hairpin RNA-mediated RNA interference.
Lambeth LS; Moore RJ; Muralitharan MS; Doran TJ
Vet Microbiol; 2007 Jan; 119(2-4):132-43. PubMed ID: 17052865
[TBL] [Abstract][Full Text] [Related]
4. Genetic change in the open reading frame of bovine viral diarrhea virus is introduced more rapidly during the establishment of a single persistent infection than from multiple acute infections.
Neill JD; Newcomer BW; Marley SD; Ridpath JF; Givens MD
Virus Res; 2011 Jun; 158(1-2):140-5. PubMed ID: 21470568
[TBL] [Abstract][Full Text] [Related]
5. Suppression of bovine viral diarrhea virus replication by single and dual short hairpin RNA-mediated RNA interference.
Ni W; Hu S; Qiao J; Yu Y; Wang D; Tong Q; Zhang Y; Chen C
Res Vet Sci; 2012 Aug; 93(1):544-8. PubMed ID: 21907372
[TBL] [Abstract][Full Text] [Related]
6. A pyrazolotriazolopyrimidinamine inhibitor of bovine viral diarrhea virus replication that targets the viral RNA-dependent RNA polymerase.
Paeshuyse J; Letellier C; Froeyen M; Dutartre H; Vrancken R; Canard B; De Clercq E; Gueiffier A; Teulade JC; Herdewijn P; Puerstinger G; Koenen F; Kerkhofs P; Baraldi PG; Neyts J
Antiviral Res; 2009 Jun; 82(3):141-7. PubMed ID: 19428605
[TBL] [Abstract][Full Text] [Related]
7. Establishment of a subgenomic replicon for bovine viral diarrhea virus in Huh-7 cells and modulation of interferon-regulated factor 3-mediated antiviral response.
Horscroft N; Bellows D; Ansari I; Lai VC; Dempsey S; Liang D; Donis R; Zhong W; Hong Z
J Virol; 2005 Mar; 79(5):2788-96. PubMed ID: 15708997
[TBL] [Abstract][Full Text] [Related]
8. Delayed onset postvaccinal mucosal disease as a result of genetic recombination between genotype 1 and genotype 2 BVDV.
Ridpath JF; Bolin SR
Virology; 1995 Sep; 212(1):259-62. PubMed ID: 7676642
[TBL] [Abstract][Full Text] [Related]
9. Isolation of a mutant MDBK cell line resistant to bovine viral diarrhea virus infection due to a block in viral entry.
Flores EF; Donis RO
Virology; 1995 Apr; 208(2):565-75. PubMed ID: 7747428
[TBL] [Abstract][Full Text] [Related]
10. Development and characterization of a stable luciferase dengue virus for high-throughput screening.
Zou G; Xu HY; Qing M; Wang QY; Shi PY
Antiviral Res; 2011 Jul; 91(1):11-9. PubMed ID: 21575658
[TBL] [Abstract][Full Text] [Related]
11. Both cytopathic and non-cytopathic bovine viral diarrhea virus (BVDV) induced autophagy at a similar rate.
Rajput MKS; Abdelsalam K; Darweesh MF; Braun LJ; Kerkvliet J; Hoppe AD; Chase CCL
Vet Immunol Immunopathol; 2017 Dec; 193-194():1-9. PubMed ID: 29129222
[TBL] [Abstract][Full Text] [Related]
12. Generation and characterization of an Npro-disrupted marker bovine viral diarrhea virus derived from a BAC cDNA.
Fan ZC; Bird RC
J Virol Methods; 2008 Aug; 151(2):257-263. PubMed ID: 18555541
[TBL] [Abstract][Full Text] [Related]
13. Characterization of protection against systemic infection and disease from experimental bovine viral diarrhea virus type 2 infection by use of a modified-live noncytopathic type 1 vaccine in calves.
Kelling CL; Hunsaker BD; Steffen DJ; Topliff CL; Eskridge KM
Am J Vet Res; 2007 Jul; 68(7):788-96. PubMed ID: 17605616
[TBL] [Abstract][Full Text] [Related]
14. Antiviral activity of geneticin against bovine viral diarrhoea virus.
Birk AV; Dubovi EJ; Zhang X; Szeto HH
Antivir Chem Chemother; 2008; 19(1):33-40. PubMed ID: 18610556
[TBL] [Abstract][Full Text] [Related]
15. Infectious bovine viral diarrhea virus (strain NADL) RNA from stable cDNA clones: a cellular insert determines NS3 production and viral cytopathogenicity.
Mendez E; Ruggli N; Collett MS; Rice CM
J Virol; 1998 Jun; 72(6):4737-45. PubMed ID: 9573238
[TBL] [Abstract][Full Text] [Related]
16. Substituted 2,6-bis(benzimidazol-2-yl)pyridines: a novel chemical class of pestivirus inhibitors that targets a hot spot for inhibition of pestivirus replication in the RNA-dependent RNA polymerase.
Musiu S; Pürstinger G; Stallinger S; Vrancken R; Haegeman A; Koenen F; Leyssen P; Froeyen M; Neyts J; Paeshuyse J
Antiviral Res; 2014 Jun; 106():71-9. PubMed ID: 24680957
[TBL] [Abstract][Full Text] [Related]
17. Retrospective genome analysis of a live vaccine strain of bovine viral diarrhea virus.
Bálint A; Baule C; Pálfi V; Belák S
Vet Res; 2005; 36(1):89-99. PubMed ID: 15610726
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of action of a pestivirus antiviral compound.
Baginski SG; Pevear DC; Seipel M; Sun SC; Benetatos CA; Chunduru SK; Rice CM; Collett MS
Proc Natl Acad Sci U S A; 2000 Jul; 97(14):7981-6. PubMed ID: 10869440
[TBL] [Abstract][Full Text] [Related]
19. Highly potent and selective inhibition of bovine viral diarrhea virus replication by γ-carboline derivatives.
Salim MT; Goto Y; Hamasaki T; Okamoto M; Aoyama H; Hashimoto Y; Musiu S; Paeshuyse J; Neyts J; Froeyen M; Herdewijn P; Baba M
Antiviral Res; 2010 Dec; 88(3):263-8. PubMed ID: 20869990
[TBL] [Abstract][Full Text] [Related]
20. Discovery of diphenylmethane analogs as anti-bovine diarrhea viral agents.
Hosoda S; Aoyama H; Goto Y; Salim MT; Okamoto M; Hashimoto M; Baba M; Hashimoto Y
Bioorg Med Chem Lett; 2009 Jun; 19(12):3157-61. PubMed ID: 19447037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
